NACDS: Floridians, all Americans deserve better than the current “pharmaceutical benefit manipulation”
Texans rank pharmacies as most accessible healthcare destination tested, and support policies that would continue to allow patient choice when it comes to accessing services.
NACDS details actions needed by Biden Administration and Congress to prevent forced rollback
Through NACDS 2023, the Association continues to advance consumer-empowered, community-focused health and wellness.
It is a two-year anniversary that patients and pharmacies can appreciate. With a unanimous decision on December 10, 2020, the U.S. Supreme Court upheld an Arkansas law that confronts the damaging tactics of prescription-drug middlemen known as pharmacy benefit managers (PBMs). NACDS had submitted an amicus brief in this case, Rutledge, Attorney General of Arkansas v. Pharmaceutical Care Management Association (PCMA).
ADM Brett P. Giroir, MD, receives 2022 Excellence in Patient Care Award.
Brings comprehensive knowledge of state and federal regulatory and legislative matters to NACDS’ advocacy efforts.
NACDS Foundation today announced the participants for the 2022-2023 Faculty Scholars Program.
Continues momentum in Tennessee and nationwide to advance patients’ health, convenience, and savings by confronting PBM tactics.
Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
